“The report shows that Glaxo [makers of Paxil] knew in 1989, long before Paxil was FDA approved, that people taking the drug were 8 times more likely to engage in suicidal behavior than people given a placebo, or sugar pill. Now, it stands to reason that even the most depressed person would decline to take Paxil if given these facts. Also, parents certainly would decline if they were told about the risks. . . . “The FDA approved Paxil on December 29, 1992, with no warning to doctors or patients of the significant increased risk of suicidal behavior,” he writes.
First of all the hypothesis behind antidepressants and atypical antipsychotics is backwards. Serotonin is not low in depression, anxiety, etc. What is low in those conditions is the ability to break down or metabolize serotonin with the end result being elevated serotonin levels. What “Selective Serotonin Reuptake Inhibitors” means is that these drugs inhibit the […]